The Journal of Infectious Diseases · 1976 · 29 citations · 11 references
Microbial PathogensLaboratory ImmunologyImmunodeficienciesImmunologyImmunogenic RnaImmunodominanceAllergenTransfer Delayed HypersensitivityMolecular ClassesInnate ImmunityImmune SystemImmunotherapyHypersensitivityCancer VaccinesAllergyAutoimmunityHumoral ImmunityImmune FunctionTolerance InductionDelayed HypersensitivityMolecular ImmunologyPathogenesisImmunomodulationImmunosuppressionSedimentation Gradient FractionsMedicineViral ImmunityRnase Preparations
The transfer of delayed hypersensitivity to Coccidioides immitis and Candida albicans antigens with immunogenic RNA extracts was studied in a mouse model. Sensitivity was measured by skin tests and footpad swelling responses. Immunogenic RNA converted normal spleen cells in vitro so that they produced antigenspecific delayed hypersensitivity in mice that were given injections of the cells. RNase reduced the rate of, but did not abolish, in vitro interaction of immunogenic RNA extracts with lymphocytes. Immunogenic RNA transferred sensitivity on direct intraperitoneal inoculation into mice. The transfer ability was resistant to RNase preparations active against both single- and double-stranded RNA. Sedimentation gradient fractions of the immunogenic RNA were assayed by intraperitoneal injection, and converting activity was found in two fractions, >33S and 6S–13S. After treatment with RNase, all activity was shifted to the <6S fraction. Two fractions of the immunogenic RNA in its native state (>33S and 6S–13S) were also able to convert spleen cells. The data indicate that the transfer of delayed hypersensitivity by immunogenic RNA preparations is associated with RNA but may not require the intact RNA molecule.
11
Effect of Nucleic Acids from Immune Lymphocytes on Rat Sarcomata
Peter Alexander, E. J. Delorme, L. D. Hamilton et al. · Nature · 1967 · 107 citations